Home / Ondansetron / Ireland
IE ATC A04AA01 · updated 2 Nov 2026
Ondansetron shortage in Ireland
Is there an Ondansetron shortage in Ireland?
Yes. As of 2 Nov 2026, 4 Ondansetron products are reported short in Ireland, the first since 23 Nov 2025. The company estimate for the return is 13 Nov 2026 (latest 30 Nov 2026). Main reason: manufacturing problem.
Also short in Canada, France, Italy, Spain, Austria, Czechia, Sweden, Japan. All countries.
Affected products in Ireland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IE | Ondansetron 8 mg film-coated tablets 10 | Teva Pharma B.V. | 23 Nov 2025 | 30 Nov 2026 | Manufacturing problem Manufacturing delay |
| IE | Zofran 4 mg film-coated tablets 30 | Rowex Limited, | 8 Jun 2026 | 16 Nov 2026 | Increased demand Unexpected increased demand |
| IE | Zofran 8 mg film-coated tablets | Rowex Limited, | 13 Jul 2026 | 13 Nov 2026 | Manufacturing problem Manufacturing delay |
| IE | Zofran 4mg / 2ml Solution for Injection or Infusion | Rowex Limited, | 18 Sep 2026 | 30 Nov 2026 | Manufacturing problem Manufacturing delay |
Source
HPRA (Health Products Regulatory Authority). Official list. Shortages notified to the HPRA by marketing-authorisation holders; one row per pack.